Trials / Completed
CompletedNCT04008446
Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients
Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients : an Observational Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an prospective observational study assessing the effect of vitamin B12 on the odds of developing sepsis in patients with infection confirmed by a positive culture result. The hypothesis is that patients with infection confirmed by positive cultures who develop sepsis have lower vitamin B12 levels than patients infection, confirmed by positive cultures, who do not develop sepsis.
Conditions
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2022-11-11
- Completion
- 2022-12-31
- First posted
- 2019-07-05
- Last updated
- 2023-01-10
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04008446. Inclusion in this directory is not an endorsement.